Rheumatoid Arthritis Registry

CorEvitas is now part of Thermo Fisher Scientific. Read More.

The CorEvitas RA Registry is the largest RA real world prospective cohort study in the world. We collect data from both physicians and patients at the time of a clinical encounter and longitudinally thereafter.

STUDY VISITS

PATIENTS

RHEUMATOLOGISTS

Participating Sites

CorEvitas has clinical sites across the U.S. and we are always interested in expanding the registry for qualified sites.

Clinical outcome measures and PROs in the CorEvitas RA Registry.

Among the variables we collect, some of the key outcome measures to inform your research include:

Calculated Outcomes

Patient Reported Outcomes

Euro-QoL Group EQ-5D-3L
Health Assessment Questionnaire (HAQ)
Patient Global Assessment
Pain Visual Analogue Scale
Morning Stiffness Visual Analogue Scale
Fatigue Visual Analogue Scale

Registry Scientific Advisors

Jeff Greenberg, MD, MPH

Chief Medical Officer, CorEvitas | Attending Physician, Institute for Rheumatic Diseases, Atlantic Health System

Dimitrios Pappas, MD, MPH

Assistant Professor of Medicine, Columbia University College of Physicians and Surgeons | Director, Division of Rheumatology, Athens Medical Center, Athens, Greece

Joshua F. Baker, MD, MSCE

Associate Professor of Medicine (Rheumatology) at the Hospital of the University of Pennsylvania and the Veteran's Administration Medical Center | Associate Professor of Epidemiology in Biostatistics and Epidemiology

Leslie Harrold, MD, MPH

Chief Scientific Officer, CorEvitas | Associate Professor of Medicine, University of Massachusetts

Stanley B. Cohen, MD

Clinical Associate Professor, University of Texas Southwestern Medical School | Director, Arthritis division of the Health South Rehabilitation Center, TX

Subscribe to our newsletter